Examkin

Soru

Zorluk: ZorOrdering Laboratory Tests

A 4848-year-old woman is evaluated in the outpatient clinic for incidentally discovered hypercalcemia. She has no acute complaints but reports mild, intermittent fatigue over the past year. She has no history of nephrolithiasis, fragility fractures, or abdominal pain. Her family history is notable for a father who had "some kind of high calcium problem" that did not require surgical intervention. She takes no medications and her vital signs are within normal limits. Physical examination is unremarkable, with no palpable neck masses or thyromegaly. Initial laboratory studies reveal the following:

Serum total calcium: 11.311.3 mg/dL
Serum albumin: 4.04.0 g/dL
Serum creatinine: 0.90.9 mg/dL
Intact parathyroid hormone (PTH): 9292 pg/mL (Normal: 1515–6565 pg/mL)
2525-hydroxyvitamin D: 3535 ng/mL (Normal: 2020–5050 ng/mL)

Which of the following is the most appropriate next step in laboratory evaluation?

  1. Measurement of 24-hour urinary calcium and creatinine excretionCevap
  2. B
    Technetium-99m sestamibi parathyroid scintigraphy
  3. C
    Measurement of serum parathyroid hormone-related peptide
  4. D
    Dual-energy x-ray absorptiometry of the spine and hip
  5. E
    Genetic testing for multiple endocrine neoplasia type 1 mutations

Cevap

The correct answer is the measurement of 24-hour urinary calcium and creatinine excretion.
The correct answer identifies the need to differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH). This patient has PTH-dependent hypercalcemia (elevated calcium with an elevated intact PTH). While primary hyperparathyroidism is the most common cause, FHH presents identically on basic serum chemistry. FHH is an autosomal dominant condition caused by a mutation in the calcium-sensing receptor (CaSR), which raises the set-point for calcium homeostasis. It is a benign condition that does not cause end-organ damage and for which parathyroidectomy is contraindicated. To safely diagnose primary hyperparathyroidism and avoid unnecessary surgery, a 2424-hour urine calcium and creatinine excretion must be evaluated to calculate the calcium-to-creatinine clearance ratio. A ratio <0.01< 0.01 indicates FHH, while a ratio >0.02> 0.02 indicates primary hyperparathyroidism.

Adım Adım Çözüm

1
Interpret the initial laboratory results.
The patient has hypercalcemia with a concurrently elevated intact PTH level (9292 pg/mL).
This biochemical profile indicates a PTH-dependent etiology for the hypercalcemia, ruling out PTH-independent causes such as malignancy or granulomatous disease.
2
Formulate the differential diagnosis for PTH-dependent hypercalcemia.
The primary considerations are primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).
Both conditions present with elevated serum calcium and inappropriately normal or elevated PTH levels. The patient's family history of a benign calcium issue further raises suspicion for FHH.
3
Select the appropriate diagnostic laboratory test to differentiate the conditions.
Order a 24-hour urine collection for calcium and creatinine.
FHH is characterized by low urinary calcium excretion (calcium-creatinine clearance ratio <0.01< 0.01), whereas primary hyperparathyroidism typically presents with normal to elevated urinary calcium excretion (ratio >0.02> 0.02).

Anahtar Kavram

The diagnostic algorithm for PTH-dependent hypercalcemia requires ruling out familial hypocalciuric hypercalcemia (FHH) via 24-hour urinary calcium excretion testing before considering imaging or parathyroidectomy.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Ordering Laboratory Tests

Bu konudan daha fazla soru